#科技头条#【制药行业将进入3D打印时代】

【制药行业将进入3D打印时代】近日,美国食品药品监督管理局首次通过一款利用3D打印技术设计的药物。这款名为SPRITAM的药物由美国Aprecia公司设计,经过3D打印设计后仅需少量水分即可速溶,10秒内能被血液吸收,有利于癫痫症患者的治疗。据称,作为国际医疗审核权威机构的FDA,这是其首次通过3D打印技术设计的药物。

QQ截图20150804081522

The FDA has just approved the world’s first 3D-printed medication, SPRITAM. The seizure drug is meant to be customized for high dosage treatments, and was developed with Aprecia’s ZipDose technology.

SPRITAM’s 3D-printed designed makes it water soluble with a minimal amount of liquid, which absorbs into the blood stream in less than 10 seconds.“By combining 3DP technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” Don Wetherhold, Aprecia’s Chief Executive Officer of Aprecia, said in a press release.

The use of 3D-printing for medical purposes is not new, but this is the first time the FDA has approved a drug designed by 3D-printing.

http://thenextweb.com/insider/2015/08/04/the-fda-has-approved-the-first-drug-designed-using-3d-printing-technology/


Comments are closed.



无觅相关文章插件